TERRACCIANO, Rosa
 Distribuzione geografica
Continente #
NA - Nord America 3.347
AS - Asia 2.157
EU - Europa 887
SA - Sud America 515
Continente sconosciuto - Info sul continente non disponibili 132
AF - Africa 47
OC - Oceania 8
Totale 7.093
Nazione #
US - Stati Uniti d'America 3.234
SG - Singapore 963
CN - Cina 538
IT - Italia 444
BR - Brasile 402
VN - Vietnam 273
IN - India 176
DE - Germania 120
SE - Svezia 91
CA - Canada 76
GB - Regno Unito 71
HK - Hong Kong 60
AR - Argentina 51
BD - Bangladesh 36
FI - Finlandia 32
MX - Messico 27
ID - Indonesia 20
IQ - Iraq 18
EC - Ecuador 17
FR - Francia 17
UA - Ucraina 17
ZA - Sudafrica 17
PL - Polonia 15
ES - Italia 14
TR - Turchia 13
NL - Olanda 12
CO - Colombia 11
PY - Paraguay 11
RU - Federazione Russa 10
VE - Venezuela 10
CZ - Repubblica Ceca 9
AT - Austria 8
AU - Australia 8
EU - Europa 7
JP - Giappone 7
TN - Tunisia 7
EG - Egitto 6
MA - Marocco 6
PK - Pakistan 6
SA - Arabia Saudita 6
UY - Uruguay 6
IR - Iran 5
UZ - Uzbekistan 5
DZ - Algeria 4
IL - Israele 4
JO - Giordania 4
LT - Lituania 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
GR - Grecia 3
RO - Romania 3
TW - Taiwan 3
BH - Bahrain 2
DO - Repubblica Dominicana 2
EE - Estonia 2
HN - Honduras 2
HR - Croazia 2
IE - Irlanda 2
JM - Giamaica 2
KE - Kenya 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
MY - Malesia 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MR - Mauritania 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 6.969
Città #
San Jose 547
Dallas 455
Chandler 310
Singapore 305
Ashburn 269
Santa Clara 170
Bengaluru 131
Hefei 131
Milan 120
Lawrence 119
Princeton 119
Council Bluffs 118
Ho Chi Minh City 105
Beijing 82
Munich 67
Catanzaro 66
Wilmington 65
Hong Kong 60
Hanoi 57
Ottawa 46
Chicago 43
São Paulo 43
London 39
Des Moines 37
Boardman 35
Shanghai 35
Troina 27
Los Angeles 26
Palermo 23
Seattle 23
New York 21
Turku 21
Guangzhou 20
Rome 20
Norwalk 19
Florence 17
Haiphong 16
Redwood City 16
Rio de Janeiro 16
Warsaw 15
Naples 13
Boston 12
The Dalles 12
Atlanta 11
Thái Bình 11
Chennai 10
Da Nang 10
Helsinki 10
Johannesburg 10
Redmond 10
San Francisco 10
Columbus 9
Curitiba 9
Mexico City 9
Orem 9
Biên Hòa 8
Cicciano 8
Hanover 8
Hải Dương 8
Olomouc 8
Brasília 7
Brooklyn 7
Campinas 7
Falls Church 7
Phoenix 7
Pune 7
Baghdad 6
Belo Horizonte 6
Brampton 6
Montevideo 6
Porto Alegre 6
Salerno 6
Stockholm 6
Washington 6
Amsterdam 5
Ankara 5
Bắc Giang 5
Cairo 5
Goiânia 5
Paris 5
Quito 5
Salvador 5
Siracusa 5
Sydney 5
Tashkent 5
Tokyo 5
Asunción 4
Bogotá 4
Bologna 4
Buenos Aires 4
Carapicuíba 4
Charlotte 4
Denver 4
Dhaka 4
Duque de Caxias 4
Girona 4
Guarulhos 4
Jinan 4
Louisville 4
Montreal 4
Totale 4.255
Nome #
Untargeted metabolomics fingerprints in seminal plasma of patients with abnormal sperm morphology using high-performance liquid chromatography and mass spectrometry 195
An interleukin-6 antagonist modified for bone targeting preserves anti-myeloma biological activity 100
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 100
Mesopore-assisted Profiling of Human Synovial Fluid 94
A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy 86
Impact of legumes and plant proteins consumption on cognitive performances in the elderly 86
Benralizumab: From the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 85
Application of proteomics and peptidomics to COPD 84
Lycopene and bone: An in vitro investigation and a pilot prospective clinical study 84
277 POSTER An interleukin-6 antagonist modified for bone targeting preserves anti-myeloma biological activity 83
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 79
An alternative approach for the identification of potential prostate cancer biomarkers 77
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma 76
Nanotechnologies for biomolecular detection and medical diagnostics 75
Enhancing plasma peptide MALDI-TOF-MS profiling by mesoporous silica assisted crystallization 74
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 73
Pseudo-Peptide Compounds as Antagonists of Neurokinines 71
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 71
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy 70
A rapid and reproducible standardized procedure for MALDI-TOF profiling of gingival crevicular fluid 70
Asthma and COPD proteomics: Current approaches and future directions 70
Peptidomic analysis of induced sputum of asthmatic patients by MSB-MALDI-TOF-MS platform 70
Interleukin-6 receptor superantagonist Sant7 inhibits TGF-beta-induced proliferation of human lung fibroblasts 70
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 69
Antinociceptive activity of ricinoleic acid, a capsaicin-like compound devoid of pungent properties 68
MALDI MS-Based Investigations Targeting SARS-CoV-2 68
Biochemical modification of an Interleukin-6 antagonist to target myeloma cells in the bone marrow microenvironment 67
Assessment of pre-analytical and analytical variables affecting peptidome profiling of gingival crevicular fluid by MALDI-TOF mass spectrometry 67
Hexagonal Mesoporous Silica as a Rapid, Efficient and Versatile Tool for MALDI-TOF MS Sample Preparation in Clinical Peptidomics Analysis: A Pilot Study. 67
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis 66
Objective and self-evaluation voice analysis after transoral laser cordectomy and radiotherapy in T1a-T1b glottic cancer 66
An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD 65
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases 65
Basic Non-Peptide Bradykinin Antagonists and Pharmaceutical Compositions Therefrom 65
Association between low bone mineral density and increased α-defensin in salivary fluid among postmenopausal women 63
Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments 63
Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations 63
The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial 63
Integrating peptidomic with lipidomic fingerprints by using mesoporous aluminosilicate and MALDI-TOF MS 63
Effect of a novel functional tomato sauce (OsteoCol) from vine-ripened tomatoes on serum lipids in individuals with common hypercholesterolemia: tomato sauce and hypercholesterolemia 63
TLR4 triggered complex inflammation in human pancreatic islets 62
Application of MSB-MALDI-TOF-MS Technology to body fluids and Tissues peptidome profiling 62
Nanoporous substrates for analytical methods 62
LEBRIKIZUMAB Anti-interleukin-13 monoclonal antibody, Treatment of asthma 62
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose 62
Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non small lung cancer cells. 61
Characteristics and clinical implications of the pharmacokinetic profile of ibuprofen in patients with knee osteoarthritis 60
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 60
Liquid Cristalline Phases for the Ophthalmic Administration of Drug 59
Benralizumab:from the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 58
Mesoporous Beads: New Tools and Strategies in Body Fluids Proteomics 58
A mass spectrometry-based proteomic approach for the identification and quantification of potential biomarkers in prostate cancer. 58
Mass Spectrometry-Based Untargeted Approaches to Reveal Diagnostic Signatures of Male Infertility in Seminal Plasma: A New Laboratory Perspective for the Clinical Management of Infertility? 57
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide 57
Identification of Novel Angiogenic Proteins in Multiple Myeloma Patient-Derived Endothelial Cells Using Proteome-Wide Analysis 56
Role of biologics in severe eosinophilic asthma - focus on reslizumab 54
Nanoporous surfaces as harvesting agents for mass spectrometric analysis of peptides in human plasma 54
C3f is a potential tool for the staging of osteoarthritis 54
Gingival Crevicular Fluid Peptidome Profiling in Healthy and in Periodontal Diseases. 54
Liposomal Delivery Improves the Growth Inhibitory and Apoptotic Activity of Low Doses of Gemcitabine in Multiple Myeloma Cancer Cells 54
Effects of simvastatin and rosuvastatin on RAS protein, matrix metalloproteinases and NF-kappa B in lung cancer and in normal pulmonary tissues 53
Mapping the SARS-CoV-2–host protein–protein interactome by affinity purification mass spectrometry and proximity-dependent biotin labeling: A rational and straightforward route to discover host-directed anti-SARS-CoV-2 therapeutics 53
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness 52
Clinical relevance of understanding mitogen-activated protein kinases involved in asthma 52
Targeted proteomic approach in prostatic tissue: a panel of potential biomarkers for cancer detection 50
Identification of Proteins Differentially Expressed in Plasma of Patients with Hereditary Breast Cancer by 2D-DIGE/MS Analysis 50
MALDI-TOF MS ANALYSIS OF LOW-ABUNDANCE PEPTIDE ENRICHED FROM BODY FLUIDS BY MESOPOROUS SILICA BEADS 50
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for biomarker discovery of Asthma and COPD 50
Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational study 50
Revealing the Hidden Diagnostic Clues of Male Infertility from Human Seminal Plasma by Dispersive Solid Phase Extraction and MALDI-TOF MS 49
Simvastatin Action Is Not Related to HDAC2 Expression in Non-Small Cell Lung Cancer (NSCLC) 49
Nanoporous substrates for the analytical methods 49
Mesopore-assisted fingerprints of gingival crevicular fluid by MALDI-TOF mass spectrometry for monitoring inflammatory state in patients wearing fixed orthodontic appliance 49
Tezepelumab: A potential new biological therapy for severe refractory asthma 48
Proteomic pattern of BRCA1-deficient and reconstituted HCC1937 breast cancer cells: correlation with sensitivity profile to mitotic spindle poisoning drugs 47
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets 47
Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma 46
Cellular Mechanisms Underlying Eosinophilic and Neutrophilic Airway Inflammation in Asthma 46
PACLITAXEL RESISTANCE OF BRCA1 MUTATED HCC1937 BREAST CANCER CELLS CORRELATES WITH CHANGES IN THE WHOLE CELL PROTEOME 46
Nanoporous silica particles, a new fast and easy procedure for biomarkers discovery in plasma peptidome 46
Selective binding and enrichment for low-molecular weight biomarker molecules in human plasma after exposure to nanoporous silica particles 46
Pharmacology of the peptidomimetic, MEN 11149, a new potent, selective and orally effective tachykinin NK1 receptor antagonist 45
Tissue Proteomics: Pathways, Biomarkers and Drug Discovery 45
Novel Biological Therapies for Severe Asthma Endotypes 44
In Mesopore Protein Digestion: A New Forthcoming Strategy in Proteomics 44
Pharmacology of MEN 11467: a potent new selective and orally-effective peptidomimetic tachykinin NK1 receptor antagonist 44
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma 44
Seminal plasma untargeted metabolomic and lipidomic profiling for the identification of a novel panel of biomarkers and therapeutic targets related to male infertility 43
The Influence of the C-terminal Fragment of a Family of NK1 Receptor Antagonists on in vitro Binding Affinity 43
Derivatized Mesoporous Silica Beads for MALDI-TOF MS Profiling of Human Plasma and Urine 43
Benralizumab: From the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 43
MALDI MS-Based Investigations for SARS-CoV-2 Detection 43
Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD 42
Peptidome profiling of gingival crevicular fluid by MALDI-TOF/TOF mass spectrometry 42
Genetics and molecular profiling of multiple myeloma: Novel tools for clinical management? 42
Simultaneous inhibition of the constitutively activated nuclear factor kappaB and of the Interleukin-6 pathways is necessary and sufficient to completely overcome apoptosis resistance of human U266 myeloma cells 41
Quantitative proteomic analysis of BRCA1-deficient and reconstituted HCC1937 breast cancer cells; Evaluation of sensitivity profile to mitotic spindle-poisoning drugs 41
Functionalized Mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine 41
The specific chemosensitivity profile of BRCA1 mutated HCC1937 cells is correlated to changes in the multi-chaperon complex but not to MDR1 expression 40
Postmenopausal women with carotid atherosclerosis: Potential role of the serum calcium levels 40
Totale 6.056
Categoria #
all - tutte 65.515
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.515


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022371 0 1 51 69 39 12 20 64 30 29 55 1
2022/2023930 242 49 55 46 105 101 9 64 133 36 66 24
2023/2024391 53 57 41 31 20 85 4 32 5 17 12 34
2024/20251.410 208 119 71 57 121 157 6 20 166 122 145 218
2025/20263.439 167 315 692 611 331 144 349 193 331 202 81 23
2026/2027205 38 167 0 0 0 0 0 0 0 0 0 0
Totale 7.093